Background Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)–related
death in sub-Saharan Africa. Whether a treatment regimen that includes a …

Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …

Background . Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of
persons with acquired immunodeficiency syndrome in Africa. Methods . Two prospective, …

Background Although antiretroviral therapy (ART) improves survival in persons with
cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution …

Background WHO recommends Xpert MTB/RIF as initial diagnostic testing for tuberculous
meningitis. However, diagnosis remains difficult, with Xpert sensitivity of about 50–70% and …

Cryptococcal antigen screening is recommended among people living with AIDS when
entering HIV care with a CD4 count of <100 cells/μl, and preemptive fluconazole monotherapy …

Background Cryptococcus is the most common cause of adult meningitis in Africa. We assessed
the safety and microbiological efficacy of adjunctive sertraline, previously shown to have …

Recent advances in the diagnosis and management of cryptococcal meningitis are promising
and have been improving long-term survival. Point of care testing has made diagnosing …

Introduction. Cryptococcal meningitis is the most common cause of adult meningitis in sub-Saharan
Africa. Raised intracranial pressure (ICP) is common in cryptococcosis. Prior studies …

BACKGROUND: TB meningitis (TBM) diagnosis is difficult and novel diagnostic methods
are needed. The World Health Organization recommends Xpert® MTB/RIF as the initial TBM …